Pro Medicus is a healthcare IT company specializing in radiology imaging software... Show more
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PMCUF advanced for three days, in of 86 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PMCUF's RSI Oscillator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where PMCUF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 15, 2025. You may want to consider a long position or call options on PMCUF as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
PMCUF moved above its 50-day moving average on August 14, 2025 date and that indicates a change from a downward trend to an upward trend.
PMCUF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 294 cases where PMCUF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Moving Average Convergence Divergence Histogram (MACD) for PMCUF turned negative on July 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMCUF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PMCUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PMCUF's P/B Ratio (126.582) is very high in comparison to the industry average of (10.946). PMCUF has a moderately high P/E Ratio (284.218) as compared to the industry average of (80.862). PMCUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.386). Dividend Yield (0.002) settles around the average of (0.063) among similar stocks. P/S Ratio (153.846) is also within normal values, averaging (86.429).
Industry ServicestotheHealthIndustry
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSTR | 28.08 | 0.06 | +0.20% |
PeakShares Sector Rotation ETF | |||
BBBI | 51.65 | -0.01 | -0.03% |
BondBloxx BBB Rated 5-10 Yr Corp Bd ETF | |||
FDEV | 32.89 | -0.02 | -0.06% |
Fidelity International Multifactor ETF | |||
VOTE | 75.80 | -0.12 | -0.16% |
TCW Transform 500 ETF | |||
IJR | 114.44 | -0.71 | -0.62% |
iShares Core S&P Small-Cap ETF |
A.I.dvisor tells us that PMCUF and OCLCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCUF and OCLCF's prices will move in lockstep.
Ticker / NAME | Correlation To PMCUF | 1D Price Change % | ||
---|---|---|---|---|
PMCUF | 100% | +2.08% | ||
OCLCF - PMCUF | 32% Poorly correlated | N/A | ||
TMSNY - PMCUF | 29% Poorly correlated | +1.10% | ||
FSLY - PMCUF | 29% Poorly correlated | +0.58% | ||
NEXXY - PMCUF | 22% Poorly correlated | N/A | ||
TMNSF - PMCUF | 21% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To PMCUF | 1D Price Change % |
---|---|---|
PMCUF | 100% | +2.08% |
Services to the Health Industry industry (96 stocks) | 10% Poorly correlated | +0.91% |
Health Services industry (440 stocks) | 7% Poorly correlated | -0.02% |